How to cope with complexity and adapt new scenarios to patient care
The last 60 years have been characterised by an increase in life expectancy and an improvement in the quality of patients' lives. Such advances, to a significant extent, can be attributed - up to 40% of the total - to the results of pharmaceutical research. However, many treatment needs remain...
Main Author: | Sergio Dompé |
---|---|
Format: | Article |
Language: | English |
Published: |
Istituto Superiore di Sanità
2011-01-01
|
Series: | Annali dell'Istituto Superiore di Sanità |
Subjects: | |
Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0021-25712011000100021&lng=en&tlng=en |
Similar Items
-
Translational research on advanced therapies
by: Filippo Belardelli, et al.
Published: (2011-01-01) -
The role of the Istituto Superiore di Sanità as the competent authority for Phase I trials in the translation of advanced therapies
by: Patrizia Popoli, et al.
Published: (2011-01-01) -
Why rare diseases?
by: Giuseppe Remuzzi, et al.
Published: (2011-01-01) -
Translating basic research in cancer patient care
by: Marcello Maugeri-Saccà, et al.
Published: (2011-01-01) -
The personalised medicine: a paradigm of evidence-based medicine
by: Dhavendra Kumar
Published: (2011-01-01)